Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Nov;27(11):986-92.
doi: 10.1007/BF01391744.

Primary gastric lymphoma. A review of 50 cases

Primary gastric lymphoma. A review of 50 cases

B Dworkin et al. Dig Dis Sci. 1982 Nov.

Abstract

The records of 50 patients with localized primary gastric lymphoma were reviewed and clinical and prognostic factors characterized. Pathologic material was reclassified according to Rappaport's, Lukes-Collins, and Lennert's Kiel classifications. Factors with the greatest prognostic significance included initial stage as determined by surgery and pathology, absolute tumor size, degree of penetration through the stomach wall, and histologic grade of the lymphoma. After surgical resection for cure, the overall 5-year disease-free survival was 47%. For stage I disease, this was 78% vs 29% for stage II (P = 0.006). Patients with lymphomas less than 5 cm in diameter had 58% 5-year disease-free survival vs 32% for those with tumors greater than 10 cm (P = 0.06). Full-thickness penetration decreased 5-year survival from 75% to 38% (P = 0.06). Patients with histologically low-grade lymphomas had a better prognosis than those with high-grade lymphomas. The most significant correlation of histology to survival was seen with the Kiel classification with a 5-year survival of 39% for centroblastic polymorphous lymphoma vs 66% for LP immunocytoma. When lymphoma recurred it developed outside the abdomen in a majority of patients. The addition of abdominal radiation therapy to surgical resection made no significant impact on survival for either stage I or II disease.

PubMed Disclaimer

References

    1. Cancer Treat Rep. 1977 Sep;61(6):971-9 - PubMed
    1. Am J Gastroenterol. 1977 Nov;68(5):485-8 - PubMed
    1. Ann Surg. 1971 May;173(5):758-66 - PubMed
    1. Am J Dig Dis. 1972 Mar;17(3):219-32 - PubMed
    1. Br J Cancer Suppl. 1975 Mar;2:425-34 - PubMed

LinkOut - more resources